Other drugs included insulin used for diabetes, vanadium + aonys in the clinical trial for type 2 diabetes, and alimentary/metabolic disease, targeting INS and SLC2A4, respectively. The gene discussed is SLC2A4; the disease is type 2 diabetes mellitus.